aTyr Pharma - Our Science
Our Science
aTyr Pharma is discovering and developing Physiocrine™ biotherapeutics to treat a wide variety of diseases, such as inflammatory, automimmune, hematopoietic and metabolic disorders. Although the aminoacyl tRNA synthetases are universal and essential components of protein synthesis machinery in all organisms, human synthetases have naturally occurring resected variants - Physiocrines™ - that are vital to human physiology. aTyr Pharma’s proprietary product engine consists of human Physiocrine™ drug candidates in development for a variety of human diseases.
